This service is more advanced with JavaScript available, learn more at http://activatejavascript.org

Reactions Weekly

May 2017, Volume 1651, Issue 1, pp 122–122 | Cite as

Doxorubicin/trastuzumab

Cardiac toxicity: case report

Case report

First Online: 13 May 2017

27 Downloads

This is a preview of subscription content, to check access.

Reference

Kim I-H, et al. Cardioprotective effect of dexrazoxane in patients with HER2-positive breast cancer who receive anthracycline based adjuvant chemotherapy followed by trastuzumab. Journal of Breast Cancer 20: 82-90, No. 1, Mar 2017. Available from: URL: http://doi.org/10.4048/jbc.2017.20.1.82 - SouthKoreaCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

About this article

Cite this article as:: Reactions Weekly (2017) 1651: 122. https://doi.org/10.1007/s40278-017-29934-7

DOI https://doi.org/10.1007/s40278-017-29934-7
Publisher Name Springer International Publishing
Print ISSN 0114-9954
Online ISSN 1179-2051

Published in cooperation with
Adis

Personalised recommendations